Update in Primary Aldosteronism
Image For Activity Cover
Availability
Registration Required
Online Meeting
Jan 30, 2025 2:00 PM - 3:00 PM EST
Cost
Member: $0.00
Non-Member: $45.00
In-Training Member: $0.00
Resident Member: $0.00
Resident Non-Member: $45.00
Credit Offered
1 AMA PRA Category 1 Credit
1 ABIM-MOC Point
1 Participation Credit
  • Course Description
  • Target Audience
  • Learning Objectives
  • Accreditation Statement
  • Faculty and Disclosures
  • Recommended

Join us for an essential webinar focused on update in the diagnosis and management of Primary Aldosteronism (PA), a frequently overlooked but treatable cause of hypertension. This comprehensive session will transform your approach to PA by introducing practical strategies to increase screening for PA, navigating the diagnostic pathway, and describing effective treatment plan and follow up.

This interactive session combines case-based learning with practical guidance, ensuring you leave with applicable knowledge to enhance your clinical practice. Whether you're managing complex hypertension cases or seeking to update your approach to PA, this webinar provides the tools needed for optimal patient care.

Format: Live webinar with Q&A session

Physicians-in-Practice and Fellows - Endocrinologists, Hypertension Specialists, and Endocrine Fellows

Upon completion of this webinar, participants will be able to:

  1. Analyze how timely identification and management of primary aldosteronism affects patient outcomes.
  2. Apply current evidence-based diagnostic algorithms for PA, including appropriate biochemical testing and subtype differentiation.
  3. Formulate treatment plans incorporating both medical and surgical approaches to PA, with emphasis on long-term monitoring of medical therapy.

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Endocrine Society has achieved Accreditation with Commendation.

AMA PRA Category 1 Credit
The Endocrine Society designates each activity in this course for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. While offering CME credits noted above, this program is not intended to provide extensive training or certification in the field.

Please note that while other accrediting bodies accept AMA PRA Category 1 credit, we can only award and report this credit for MDs/DOs. For those outside of this accreditation, please complete the participation evaluation and use that certificate as proof of attendance to submit to your accrediting body.

Maintenance of Certification (MOC)
Successful completion of each CME activity in this course, which includes participation in the evaluation component, enables the participant to earn up to 1 points in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

For questions about content or obtaining CME credit, please contact the Endocrine Society at info@endocrine.org

Kidmealem Zekarias, MD
Assistant Professor, University of Minnesota 

As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s peer reviewers.

DISCLOSURE POLICY
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.

The Endocrine Society staff involved in the development of this CME activity reported no relevant financial relationships.

The Endocrine Society staff have reviewed all disclosures and resolved or managed all relevant identified conflicts of interest, as applicable.

   
     EndoCareers | Contact Us | Privacy Policy | Terms of Use CONNECT WITH US                
       © 2021 Copyright Endocrine Society. All rights reserved.
2055 L Street NW, Suite 600 | Washington, DC 20036      
 202.971.3636 | 888.363.6274
      
   
Android App Download IOS App Download Powered By